IL-33 potentiates histaminergic itch

Area of Science:

• Immunology
• Dermatology
• Neuroscience

Background:

• Itch significantly impacts quality of life, with antihistamines often failing in conditions like chronic spontaneous urticaria (CSU).
• Mechanisms underlying antihistamine resistance in chronic itch are not well understood.
• The alarmin cytokine IL-33 is hypothesized to drive chronic itch via sensory neuron sensitization.

Purpose of the Study:

• To investigate whether IL-33 can enhance histamine-induced (histaminergic) itch.
• To elucidate the cellular and molecular mechanisms by which IL-33 influences itch.

Main Methods:

• Assessed itch behavior in mice following IL-33 or saline administration before histamine challenge.
• Utilized knockout mouse models and transcriptomic analyses (scRNA-seq, microarrays) of human and mouse skin.
• Examined mast cell responses and IL-13 production upon IL-33 stimulation.

Main Results:

• IL-33 amplifies histaminergic itch independently of sensory neuron signaling.
• Mast cells are primary expressors of the IL-33 receptor in skin.
• IL-33 stimulation of mast cells significantly increases IL-13 production, mediating enhanced itch.
• IL-33 receptor expression is elevated in CSU lesional skin.

Conclusions:

• IL-33 signaling, acting through mast cells and IL-13, is a key mechanism amplifying histaminergic itch.
• These findings highlight IL-33 as a potential therapeutic target for mast cell-driven pruritic conditions like CSU.